Francisco Javier Novo (Francisco J Novo)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 9

Top Topics

Chronic Lymphocytic Leukemia

Prognostic Factors

Diffuse Large B Cell Lymphoma

Top Venues

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Javier Melchor, Marcos Garcia-Lacarte, Sara C Grijalba, Adrián Arnaiz-Leché, Marién Pascual, Carlos Panizo, Oscar Blanco, Victor Segura, Francisco Javier Novo, Juan Garcia Valero, Patricia Pérez-Galán, Jose-Angel Martinez-Climent, Sergio Roa
Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma. Journal for immunotherapy of cancer 11 (2) (2023)
Ana Guijarro-Hernández, Laura Eder-Azanza, Cristina Hurtado, David Navarro-Herrera, Begoña Ezcurra, Francisco Javier Novo, Juan Cabello, José Luis Vizmanos
Transcriptomic Analysis Reveals JAK2/MPL-Independent Effects of Calreticulin Mutations in a C. elegans Model. Cells 12 (1) (2023)
Javier Melchor, Marcos Garcia-Lacarte, Sara C Grijalba, Adrián Arnaiz-Leché, Marién Pascual, Carlos Panizo, Oscar Blanco, Victor Segura, Francisco Javier Novo, Juan Garcia Valero, Patricia Pérez-Galán, Jose-Angel Martinez-Climent, Sergio Roa
Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma. Journal for immunotherapy of cancer 11 (2) (2023)
Ana Guijarro-Hernández, Laura Eder-Azanza, Cristina Hurtado, David Navarro-Herrera, Begoña Ezcurra, Francisco Javier Novo, Juan Cabello, José Luis Vizmanos
Transcriptomic Analysis Reveals JAK2/MPL-Independent Effects of Calreticulin Mutations in a C. elegans Model. Cells 12 (1) (2023)
Javier Melchor, Marcos Garcia-Lacarte, Sara C Grijalba, Adrián Arnaiz-Leché, Marién Pascual, Carlos Panizo, Oscar Blanco, Victor Segura, Francisco Javier Novo, Juan Garcia Valero, Patricia Pérez-Galán, Jose-Angel Martinez-Climent, Sergio Roa
Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma. Journal for immunotherapy of cancer 11 (2) (2023)
Javier Melchor, Marcos Garcia-Lacarte, Sara C Grijalba, Adrián Arnaiz-Leché, Marién Pascual, Carlos Panizo, Oscar Blanco, Victor Segura, Francisco Javier Novo, Juan Garcia Valero, Patricia Pérez-Galán, Jose-Angel Martinez-Climent, Sergio Roa
Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma. Journal for immunotherapy of cancer 11 (2) (2023)
Ana Guijarro-Hernández, Laura Eder-Azanza, Cristina Hurtado, David Navarro-Herrera, Begoña Ezcurra, Francisco Javier Novo, Juan Cabello, José Luis Vizmanos
Transcriptomic Analysis Reveals JAK2/MPL-Independent Effects of Calreticulin Mutations in a C. elegans Model. Cells 12 (1) (2023)
Ana Guijarro-Hernández, Laura Eder-Azanza, Cristina Hurtado, David Navarro-Herrera, Begoña Ezcurra, Francisco Javier Novo, Juan Cabello, José Luis Vizmanos
Transcriptomic Analysis Reveals JAK2/MPL-Independent Effects of Calreticulin Mutations in a C. elegans Model. Cells 12 (1) (2023)
Ana Guijarro-Hernández, Laura Eder-Azanza, Cristina Hurtado, David Navarro-Herrera, Begoña Ezcurra, Francisco Javier Novo, Juan Cabello, José Luis Vizmanos
Transcriptomic Analysis Reveals JAK2/MPL-Independent Effects of Calreticulin Mutations in a C. elegans Model. Cells 12 (1) (2023)